Supplementation of Nitric Oxide Attenuates AβPP and BACE1 Protein in Cerebral Microcirculation of eNOS-Deficient Mice

Susan A. Austin, Livius V. D'uscio, Zvonimir S. Katusic

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Recently, we demonstrated in endothelial nitric oxide synthase deficient (eNOS-/-) mice that loss of endothelial NO led to increased protein levels of amyloid-β protein precursor (AβPP), β-site AβPP cleaving enzyme 1 (BACE1), and amyloid-β (Aβ) peptide. Therefore, our aim was to determine if NO supplementation in vivo would attenuate AβPP and BACE1 protein levels. cGMP levels were significantly increased while AβPP and BACE1 protein levels were statistically lower in cerebral microvessels from nitroglycerin-treated eNOS-/- mice as compared to vehicle-treated mice. Our findings support the concept that preservation of NO/cGMP signaling is an important modulator of expression and processing of AβPP.

Original languageEnglish (US)
Pages (from-to)29-33
Number of pages5
JournalJournal of Alzheimer's Disease
Volume33
Issue number1
DOIs
StatePublished - 2013

Keywords

  • Alzheimer's disease
  • amyloid-β
  • amyloid-β protein precursor
  • endothelial nitric oxide synthase
  • nitric oxide
  • vascular endothelial cells

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Supplementation of Nitric Oxide Attenuates AβPP and BACE1 Protein in Cerebral Microcirculation of eNOS-Deficient Mice'. Together they form a unique fingerprint.

Cite this